{
    "clinical_study": {
        "@rank": "8150", 
        "acronym": "SABATO", 
        "arm_group": [
            {
                "arm_group_label": "Orally administered antibiotic", 
                "arm_group_type": "Experimental", 
                "description": "First choice (MRSA and MSSA): trimethoprim-sulfamethoxazole, or Second choice (MSSA): clindamycin, or Second choice (MRSA): linezolid administered for 7-9 days"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "arm_group_type": "Experimental", 
                "description": "First choice (MSSA): flucloxacillin [Spain: cloxacillin], or cefazolin or Second choice (MSSA): vancomycin, or First choice (MRSA): vancomycin, or Second choice (MRSA): daptomycin administered for 7-9 days"
            }
        ], 
        "brief_summary": {
            "textblock": "Increasing resistance to antibiotic agents has been recognized as a major health problem\n      worldwide that will even aggravate due to the lack of new antimicrobial agents within the\n      next decade [1]. This threat underscores the need to maximize clinical utility of existing\n      antibiotics, through more rational prescription, e.g. optimizing duration of treatment.\n\n      Staphylococcus aureus bloodstream infection (SAB) is a common disease with about 200,000\n      cases occurring annually in Europe [2]. A course of at least 14 days of intravenous\n      antimicrobials is considered standard therapy [3-5] in \"uncomplicated\" SAB. This relatively\n      long course serves to prevent SAB-related complications (such as endocarditis and vertebral\n      osteomyelitis) that may result from hematogenous dissemination to distant sites. However,\n      there is insufficient evidence that a full course of intravenous antibiotic therapy is\n      always required in patients with a low risk of SAB-related complications.\n\n      In a multicenter, open-label, randomized controlled trial we aim to demonstrate that an\n      early switch from intravenous to oral antimicrobial therapy is non-inferior to a\n      conventional 14-days course of intravenous therapy regarding efficacy and safety. An early\n      switch from intravenous to oral therapy would provide several benefits such as earlier\n      discharge, fewer adverse reactions associated with intravenous therapy, increased quality of\n      life, and cost savings."
        }, 
        "brief_title": "Staphylococcus Aureus Bacteremia Antibiotic Treatment Options", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Staphylococcus Aureus Bloodstream Infection", 
        "condition_browse": {
            "mesh_term": "Staphylococcal Infections"
        }, 
        "detailed_description": {
            "textblock": "1. WHO. WHO Global Strategy for Containment of Antimicrobial Resistance.: World Health\n           Organization, 2001.\n\n        2. Kern WV. Management of Staphylococcus aureus bacteremia and endocarditis: progresses\n           and challenges. Curr Opin Infect Dis 2010;23(4):346-58.\n\n        3. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE. Guidelines for the\n           prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA)\n           infections in the UK. J Antimicrob Chemother 2006;57(4):589-608.\n\n        4. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious\n           Diseases Society of America for the treatment of methicillin-resistant Staphylococcus\n           aureus infections in adults and children. Clin Infect Dis 2011;52(3):e18-55.\n\n        5. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and\n           management of intravascular catheter-related infection: 2009 Update by the Infectious\n           Diseases Society of America. Clin Infect Dis 2009;49(1):1-45."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age at least 18 years\n\n          -  Not legally incapacitated\n\n          -  Written informed consent from the trial subject has been obtained\n\n          -  Blood culture positive for S. aureus\n\n          -  At least one negative follow-up blood culture obtained within 48-72 hours after the\n             start of adequate therapy\n\n          -  Five to seven full days of appropriate i.v. antimicrobial therapy administered prior\n             to randomization.\n\n        Exclusion Criteria:\n\n          -  Polymicrobial bloodstream infection\n\n          -  Recent history of prior S. aureus bloodstream infection\n\n          -  In vitro resistance of S. aureus to all oral or all i.v. study drugs\n\n          -  Contraindications for all oral or all i.v. study drugs\n\n          -  Signs and symptoms of complicated SAB as judged by an ID physician, such as\n             deep-seated focus,septic shock, prolonged bacteremia, fever on two occasions within\n             48h before randomization,presence of non-removable foreign body.\n\n          -  Failure to remove (within 4 days) any intravascular catheter, which is present when\n             first positive blood culture was drawn\n\n          -  Severe liver disease\n\n          -  End-stage renal disease\n\n          -  Severe immunodeficiency (e.g. primary immunodeficiency disorders, neutropenia CD4+\n             T-cell count <200/\u00b5l in HIV-positive patients, high-dose steroid therapy, recent\n             hematopoietic stem cell transplantation, solid organ transplant)\n\n          -  \"Do not resuscitate\"-order or life expectancy < 3 months\n\n          -  Inability to take oral drugs\n\n          -  Injection drug user\n\n          -  Expected low compliance with drug regimen\n\n          -  Participation in other interventional trials\n\n          -  Pregnant women and nursing mothers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "430", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792804", 
            "org_study_id": "Uni-Koeln-1400", 
            "secondary_id": "2013-000577-77"
        }, 
        "intervention": [
            {
                "arm_group_label": "Orally administered antibiotic", 
                "intervention_name": "Trimethoprim-Sulfamethoxazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Orally administered antibiotic", 
                "intervention_name": "Clindamycin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Orally administered antibiotic", 
                "intervention_name": "Linezolid", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "intervention_name": "Flucloxacillin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "intervention_name": "Cloxacillin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "intervention_name": "Vancomycin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "intervention_name": "Daptomycin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Intravenously administered antibiotic", 
                "intervention_name": "Cefazolin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Cefazolin", 
                "Clindamycin", 
                "Clindamycin-2-phosphate", 
                "Cloxacillin", 
                "Floxacillin", 
                "Vancomycin", 
                "Daptomycin", 
                "Antibiotics, Antitubercular", 
                "Linezolid", 
                "Sulfamethoxazole", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Staphylococcus aureus", 
            "Bloodstream infection", 
            "Oral switch"
        ], 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany", 
                        "zip": "52074"
                    }, 
                    "name": "Aachen"
                }, 
                "investigator": {
                    "last_name": "Sebastian Lemmen, Prof.Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "12157"
                    }, 
                    "name": "Berlin"
                }, 
                "investigator": {
                    "last_name": "Keikawus Arast\u00e9h, PD Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "christian.bernasch@uk-koeln.de", 
                    "last_name": "Bernasch"
                }, 
                "facility": {
                    "address": {
                        "city": "Cologne", 
                        "country": "Germany", 
                        "zip": "50935"
                    }, 
                    "name": "Uniklinik K\u00f6ln"
                }, 
                "investigator": {
                    "last_name": "Gerd F\u00e4tkenheuer, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt/Main", 
                        "country": "Germany", 
                        "zip": "60590"
                    }, 
                    "name": "Frankfurt"
                }, 
                "investigator": {
                    "last_name": "Christoph Stephan, PD Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Freiburg"
                }, 
                "investigator": {
                    "last_name": "Winfried V Kern, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Hannover"
                }, 
                "investigator": {
                    "last_name": "Tobias Welte, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "07743"
                    }, 
                    "name": "Jena"
                }, 
                "investigator": {
                    "last_name": "Matthias Pletz, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krefeld", 
                        "country": "Germany", 
                        "zip": "47805"
                    }, 
                    "name": "Krefeld"
                }, 
                "investigator": {
                    "last_name": "Katrin K\u00f6sters, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leverkusen", 
                        "country": "Germany", 
                        "zip": "51375"
                    }, 
                    "name": "Leverkusen"
                }, 
                "investigator": {
                    "last_name": "Stefan Reuter, PD Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "L\u00fcbeck", 
                        "country": "Germany", 
                        "zip": "23562"
                    }, 
                    "name": "L\u00fcbeck"
                }, 
                "investigator": {
                    "last_name": "Jan Rupp, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "zip": "93053"
                    }, 
                    "name": "Regensburg"
                }, 
                "investigator": {
                    "last_name": "Bernd Salzberger, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89081"
                    }, 
                    "name": "Ulm"
                }, 
                "investigator": {
                    "last_name": "Georg H\u00e4rtner, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Amsterdam"
                }, 
                "investigator": {
                    "last_name": "Jan T.M. van der Meer, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Breda", 
                        "country": "Netherlands", 
                        "zip": "4814 CK Breda"
                    }, 
                    "name": "Breda"
                }, 
                "investigator": {
                    "last_name": "Jan Kluytmans, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9700 RB"
                    }, 
                    "name": "Groningen"
                }, 
                "investigator": {
                    "last_name": "Sander van Assen, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5022GC"
                    }, 
                    "name": "Tilburg"
                }, 
                "investigator": {
                    "last_name": "Jan Kluytmans, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584 CX"
                    }, 
                    "name": "Utrecht"
                }, 
                "investigator": {
                    "last_name": "Marc Bonten, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Barcelona I"
                }, 
                "investigator": {
                    "last_name": "Alex Soriano, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Barcelona II"
                }, 
                "investigator": {
                    "last_name": "Benito Almirante, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41071"
                    }, 
                    "name": "Sevilla"
                }, 
                "investigator": {
                    "last_name": "Jesus Rodr\u00edguez-Ba\u00f1o, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41071"
                    }, 
                    "name": "Sevilla II"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Cisneros, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "zip": "NG7 24 H"
                    }, 
                    "name": "Nottingham"
                }, 
                "investigator": {
                    "last_name": "David Turner, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Netherlands", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection", 
        "other_outcome": [
            {
                "description": "Clostridium difficile associated diarrhea (CDAD)", 
                "measure": "Clostridium difficile associated diarrhea (CDAD)", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Adverse events", 
                "measure": "AEs and SAEs", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }
        ], 
        "overall_contact": {
            "last_name": "Achim J Kaasch, MD", 
            "phone": "+4922147832100"
        }, 
        "overall_contact_backup": {
            "last_name": "Christian M Bernasch"
        }, 
        "overall_official": {
            "affiliation": "University of Cologne", 
            "last_name": "Achim J Kaasch, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Netherlands: Medicines Evaluation Board (MEB)", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "S. aureus bloodstream infection-related complications (relapsing SAB, deep-seated infection with S. aureus, or attributable mortality) within 90 days", 
            "measure": "SAB-related complications", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792804"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Cologne", 
            "investigator_full_name": "Gerd F\u00e4tkenheuer", 
            "investigator_title": "Prof. Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Length of hospital stay", 
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Survival at 14, 30, and 90 days", 
                "measure": "Survival", 
                "safety_issue": "No", 
                "time_frame": "14, 30, and 90 days"
            }, 
            {
                "description": "Complications of intravenous therapy, such as thrombophlebitis.", 
                "measure": "Complications of intravenous therapy", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }
        ], 
        "source": "University of Cologne", 
        "sponsors": {
            "collaborator": {
                "agency": "German Research Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Cologne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}